Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers
- PMID: 19341246
- DOI: 10.1021/pr801091k
Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers
Abstract
Cell surface membrane proteins are involved in central processes such as cell signaling, cell-cell interactions, ion and solute transport, and they seem to play a pivotal role in several steps of the metastatic process of cancer cells. The low abundance and hydrophobic nature of cell surface membrane proteins complicate their purification and identification by MS. We used two isogenic cell lines with opposite metastatic capabilities in nude mice to optimize cell surface membrane protein purification and to identify potential novel markers of metastatic cancer. The cell surface membrane proteins were isolated by centrifugation/ultracentrifugation steps, followed by membrane separation using a Percoll/sucrose density gradient. The gradient fractions containing the cell surface membrane proteins were identified by enzymatic assays. Stable isotope labeling of the proteome of the metastatic cell line by SILAC followed by mass spectrometry analysis enabled identification and quantification of proteins that were differentially expressed in the two cell lines. Dual stable isotopic labels ((13)C-arginine and (13)C-lysine) instead of a single label ((13)C-arginine) increased the percentage of proteins that could be quantified from 40 to 93%. Repeated LC-MS/MS analyses (3-4 times) of each sample increased the number of identified proteins by 60%. The use of Percoll/sucrose density separation allowed subfractionation of membranes leading to enrichment of membrane proteins (66%) and reduction from 33% to only 16% of protein from other membranous organelles such as endoplasmatic reticulum, Golgi, and mitochondria. In total, our optimized methods resulted in 1919 protein identifications (corresponding to 826 at similarity level 80% (SL80); 1145 (509 at SL80) were identified by two or more peptides of which 622 (300 at SL80) were membrane proteins. The quantitative proteomic analysis identified 16 cell surface proteins as potential markers of the ability of breast cancer cells to form distant metastases.
Similar articles
-
Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.J Proteome Res. 2009 Jan;8(1):362-73. doi: 10.1021/pr800622b. J Proteome Res. 2009. PMID: 19053527
-
Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma.J Proteome Res. 2006 Oct;5(10):2632-41. doi: 10.1021/pr060125o. J Proteome Res. 2006. PMID: 17022634
-
Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.J Proteome Res. 2010 Mar 5;9(3):1302-22. doi: 10.1021/pr900825t. J Proteome Res. 2010. PMID: 20052998
-
Use of monolithic supports in proteomics technology.J Chromatogr A. 2007 Mar 9;1144(1):2-13. doi: 10.1016/j.chroma.2006.11.082. Epub 2006 Dec 15. J Chromatogr A. 2007. PMID: 17174320 Review.
-
Membrane proteomics for leukemia classification and drug target identification.Curr Opin Mol Ther. 2009 Dec;11(6):603-10. Curr Opin Mol Ther. 2009. PMID: 20072937 Review.
Cited by
-
Recent Advances in Glycoproteomic Analysis by Mass Spectrometry.Anal Chem. 2020 Jan 7;92(1):267-291. doi: 10.1021/acs.analchem.9b04651. Epub 2019 Nov 4. Anal Chem. 2020. PMID: 31626732 Free PMC article. Review. No abstract available.
-
NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.Mol Cell Proteomics. 2015 Nov;14(11):2988-99. doi: 10.1074/mcp.M115.050385. Epub 2015 Sep 8. Mol Cell Proteomics. 2015. PMID: 26351264 Free PMC article.
-
Plasma membrane proteomics and its application in clinical cancer biomarker discovery.Mol Cell Proteomics. 2010 Jul;9(7):1369-82. doi: 10.1074/mcp.R900006-MCP200. Epub 2010 Apr 8. Mol Cell Proteomics. 2010. PMID: 20382631 Free PMC article. Review.
-
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.Br J Cancer. 2013 Oct 15;109(8):2142-54. doi: 10.1038/bjc.2013.578. Epub 2013 Sep 24. Br J Cancer. 2013. PMID: 24064975 Free PMC article.
-
miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.Oncotarget. 2015 Oct 6;6(30):29224-39. doi: 10.18632/oncotarget.4942. Oncotarget. 2015. PMID: 26317550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical